Prognostic Impact Of Molecular Mutations In 182 Patients With Myelodysplastic Syndromes

被引：1
|
作者：
Kuendgen, Andrea
Seidler, Jenny
Lauseker, Michael
Haferlach, Torsten
Schnittger, Susanne
Kohlmann, Alexander
Hildebrandt, Barbara
Mueller-Thomas, Catharina
Betz, Beate
Haas, Rainer
Gattermann, Norbert
Royer-Pokora, Brigitte
Goetze, Katharina
Germing, Ulrich
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.2758.2758
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2758
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Molecular Techniques and Gene Mutations in Myelodysplastic Syndromes
    Mendoza, Hadrian
    Siddon, Alexa J.
    CLINICS IN LABORATORY MEDICINE, 2023, 43 (04) : 549 - 563
  • [12] Prognostic impact of ASXL1 mutations in patients with myelodysplastic syndromes and multilineage dysplasia with or without ring sideroblasts
    Mangaonkar, Abhishek A.
    Gangat, Naseema
    Al-Kali, Aref
    Elliot, Michelle A.
    Begna, Kebede H.
    Hanson, Curtis A.
    Ketterling, Rhett P.
    Wolanskyj-Spinner, Alexandra P.
    Hogan, William J.
    Litzow, Mark R.
    Patnaik, Mrinal M.
    LEUKEMIA RESEARCH, 2018, 71 : 60 - 62
  • [13] Impact of splicing factor mutations on clinical features in patients with myelodysplastic syndromes
    Naoki Shingai
    Yuka Harada
    Hiroko Iizuka
    Yosuke Ogata
    Noriko Doki
    Kazuteru Ohashi
    Masao Hagihara
    Norio Komatsu
    Hironori Harada
    International Journal of Hematology, 2018, 108 : 598 - 606
  • [14] Impact of splicing factor mutations on clinical features in patients with myelodysplastic syndromes
    Shingai, Naoki
    Harada, Yuka
    Iizuka, Hiroko
    Ogata, Yosuke
    Doki, Noriko
    Ohashi, Kazuteru
    Hagihara, Masao
    Komatsu, Norio
    Harada, Hironori
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 108 (06) : 598 - 606
  • [15] Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes
    Kewan, Tariq
    Bahaj, Waled
    Durmaz, Arda
    Aly, Mai
    Ogbue, Olisaemeka D.
    Carraway, Hetty E.
    Sekeres, Mikkael A.
    Visconte, Valeria
    Gurnari, Carmelo
    Maciejewski, Jaroslaw P.
    BLOOD, 2023, 141 (14) : 1768 - 1772
  • [16] MOLECULAR PATHOGENESIS AND PROGNOSTIC STRATIFICATION OF MYELODYSPLASTIC SYNDROMES
    Cazzola, M.
    HAEMATOLOGICA, 2022, 107 : 1 - 2
  • [17] Prognostic impact of micromegakaryocytes in primary myelodysplastic syndromes
    Saumell, Silvia
    Fernandez-Serrano, Miranda
    Mesa, Alba
    Lopez-Cadenas, Felix
    Arenillas, Leonor
    Alfonso, Ana
    Julia Montoro, Maria
    Molero, Antonieta
    Leoz, Pilar
    Riego, Victoria
    Gallur, Laura
    Salamero, Olga
    Navarrete, Mayda
    Tazon-Vega, Barbara
    Ortega, Margarita
    Reig, Oscar
    Roue, Gael
    Calvo, Xavier
    Prosper, Felipe
    Diez-Campelo, Maria
    Valcarcel, David
    LEUKEMIA & LYMPHOMA, 2022, 63 (05) : 1227 - 1235
  • [18] Clinicopathologic correlates and prognostic impact of lymphoid aggregates in patients with myelodysplastic syndromes
    Baranwal, Anmol
    Shah, Mithun V.
    Greipp, Patricia
    Shi, Min
    Reichard, Kaaren K.
    Jevremovic, Dragan
    Gangat, Naseema
    Patnaik, Mrinal M.
    Begna, Kebede H.
    Alkhateeb, Hassan B.
    Litzow, Mark R.
    Hogan, William J.
    Tefferi, Ayalew
    Al-Kali, Aref
    Mangaonkar, Abhishek A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (04) : 1627 - 1631
  • [19] PROGNOSTIC SIGNIFICANT OF ASXL1 MUTATIONS IN MYELODYSPLASTIC SYNDROMES
    Wang, S. Y.
    Lin, Y.
    Zheng, Y.
    Wang, Z. C.
    HAEMATOLOGICA, 2016, 101 : 501 - 501
  • [20] Mitochondrial tRNA mutations in patients with myelodysplastic syndromes
    Wang, Hui-rui
    Li, Ya-wei
    Wu, Jun-long
    Guo, Shu-li
    MITOCHONDRIAL DNA PART A, 2016, 27 (04) : 2315 - 2317
12345